This webinar is important to attend to learn about the spread, virus mutation classifications and reporting requirements for mpox.
On August 14, 2024, the World Health Organization (WHO) declared mpox a global emergency once again. This latest outbreak is exacerbated by a more virulent strain known as clade 1b, which poses a significant threat to global communities.
Every laboratory should proactively prepare for the potential arrival of this virus in the U.S. by understanding the evolution of Mpox transmission and becoming familiar with Mpox clade classifications for accurate diagnosis, tracking, and outbreak control. Labs must be well-versed in best practices for data submission and public health compliance to ensure timely identification and reporting of cases.
In this webinar, we will delve into diverse causes of cutaneous ulcers, examining outcomes of the mpox virus infection that could lead to autoimmune diseases, and chronic conditions. We will provide a thorough overview of mpox symptoms, clinical manifestations and discuss effective management and treatment strategies.
Join us for this 60-minute discussion with live Q&A on Tuesday, October 29, 2024 at 1pm ET.
Key Learnings
- Why This Outbreak Could Be More Dangerous: Understand the factors that make this mpox outbreak more severe and why it might spread to the U.S. more rapidly.
- Physical Manifestations: Learn about the transmission, various symptoms of mpox, including cutaneous ulcers and other visible signs.
- Virus Classification: Explore the different clads of the mpox virus and why understanding these classifications is crucial for effective management and response.
- Reporting Requirements: Know the specific criteria and timing for reporting suspected cases of mpox from your lab to state health agencies.
Dark Daily is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program.
This program offers:
P.A.C.E.® Contact Hours: 1.0
Instruction Level: Intermediate.
P.A.C.E.® is a registered trademark of the American Society for Clinical Laboratory Science.
Who Should Attend
- Laboratory Administrators
- Laboratory Directors
- Laboratory Managers, Supervisors, and Professionals
Expert Speaker
Ryan F. Relich, PhD
Associate Professor of Clinical Pathology, Medical Director – IU Health Division of Clinical Microbiology, Medical Director, IU Health Donor Screening Laboratory and Medical Director, IU Health Special Pathogens Unit Laboratory
Dr. Ryan F. Relich is an American Board of Medical Microbiology-certified medical microbiologist who is passionately interested in all facets of diagnostic microbiology, especially laboratory directorship, infectious disease epidemiology and pathology, new diagnostic test development and evaluation, pathogen discovery, and viral ecology. In his current academic position at the Indiana University School of Medicine, he is actively involved in fellow, resident, and student teaching, and is the Director of the IU School of Medicine's CPEP-accredited Medical and Public Health Laboratory Microbiology Fellowship Program. He is actively involved in research concerning in vitro diagnostic product development, clinical trials, and emerging virus ecology. As an employee of Indiana University Health, Dr. Relich serves as the Medical Director of the Division of Clinical Microbiology, Medical Director of the Special Pathogens Unit Laboratory, and Interim Medical Director of the Division of Molecular Pathology. Dr. Relich is immensely interested in the ecology of emerging viruses, pandemic preparedness, development of dignostics for novel viruses, virus discovery and characterization, and establishing best practices for manipulating highly infectious clinical specimens for routine diagnostic testing.